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CAP, a protein from Saccharomyces cerevisiae that copurifies with adenylyl cyclase, appears to be required
for yeast cells to be fully responsive to RAS proteins. CAP also appears to be required for normal cell
morphology and responsiveness to nutrient deprivation and excess. We describe here a molecular and
phenotypic analysis of the CAP protein. The N-terminal domain is necessary and sufficient for cellular response
to activated RAS protein, while the C-terminal domain is necessary and sufficient for normal cellular
morphology and responses to nutrient extremes. Thus, CAP is a novel example of a bifunctional component
involved in the regulation of diverse signal transduction pathways.
RAS proteins are highly conserved in evolution (27), and
homologs of the mammalian RAS oncogenes are found in
yeasts (6, 10, 22). RAS proteins stimulate adenylyl cyclase in
the yeast Saccharomyces cerevisiae (4, 30), but the function
of RAS in other yeasts and vertebrates is not known.
Mammalian RAS proteins can stimulate yeast adenylyl cy-
clase, but they appear incapable of stimulating vertebrate
adenylyl cyclase (2, 3). We have been studying the function
ofRAS in yeast cells in the hope that this will lead to insights
into the function of RAS in other organisms.
S. cerevisiae contains the RAS genes RASJ and RAS2.
Their major role appears to be the control of adenylyl
cyclase. Deficiencies in RAS function lead to the failure to
grow, and these defects can be suppressed by activation of
the cyclic AMP-dependent protein kinase (30). Activated
mutant alleles of RAS2, such as RAS2va l9, lead to pheno-
types essentially identical to phenotypes which result from
activation of the cyclic AMP pathway (14, 25). These phe-
notypes include an exquisite sensitivity to heat shock and
nitrogen deprivation. However, certain experiments indicate
that RAS proteins may have other functions in S. cerevisiae
as well (31), and it has never been demonstrated that RAS
proteins interact directly with the adenylyl cyclase catalytic
protein. To explore more carefully the nature ofRAS protein
interaction with yeast adenylyl cyclase, we purified a RAS-
responsive adenylyl cyclase complex from S. cerevisiae. In
this complex was a protein we called CAP, for cyclase-
associated protein (8, 9). The gene encoding CAP (CAP) was
isolated and was found to encode a protein of 526 amino
acids (9). A gene identical to CAP was isolated independent-
ly by others (7), who called it SRV2. Yeast cells having
disruptions in the CAP gene display a complex set of
phenotypes: they appear unresponsive to activated
RAS2Val-l9, in that this allele no longer induces heat shock
sensitivity, yet they are exquisitely sensitive to nutrient
extremes; they are temperature sensitive; and they show
gross morphological abnormalities (7, 9). The first phenotype
clearly places CAP on the RAS/adenylyl cyclase pathway,
but the other phenotypes suggest that CAP has other func-
tions. Here we report that CAP is indeed bifunctional, and
we have localized these functions to separate domains on the
* Corresponding author.
protein. These conclusions were foreshadowed by an allele
of CAP that we called supC. supC strains are resistant to the
effects of the activated RAS2Val-9 gene but do not display
the other defects of cap mutant strains (9).
MATERIALS AND METHODS
Microbial culture. Standard methods were used to intro-
duce plasmids into the various yeast strains (26). Strains
were grown at 30°C in either rich medium (YPD; yeast
extract-Bacto-Peptone-dextrose), synthetic complete mini-
mal medium (SC), or SC drop-out medium lacking an essen-
tial amino acid or nucleotide base. The drop-out media used
included SC lacking leucine (SC-leu), SC lacking histidine
(SC-his), SC lacking uracil (SC-ura), and SC lacking both
histidine and uracil (SC-his,ura). Drop-out media were used
to maintain plasmids. Growth media were prepared accord-
ing to Sherman et al. (26). Yeast extract, Bacto-Peptone,
Casamino Acids, and yeast nitrogen base (YNB, lacking
both ammonium sulfate and amino acids) were purchased
from Difco. Amino acids used in cell culture were purchased
from Sigma. Yeast strains SKN34 and SKN37 were grown
either on SC medium or on SC medium lacking valine (a
nonessential amino acid) unless otherwise indicated. Esche-
richia coli HB101 was used for plasmid transformations and
plasmid DNA preparations (17).
Yeast strains. Yeast strains SP1 (MATa leu2 his3 ura3 trpl
ade8 cani) and TK161-R2V (MATa leu2 his3 ura3 trpl ade8
cani RAS2Val-19) have been described previously (30), as
have strains SKN34 (Mata leu2 ura3 trpl ade8 can] cap::
HIS3), SKN37 (Mata leu2 ura3 trpl ade8 cani RAS2Val-l9
cap: :HIS3), and TKR1-2LS (Mata leu2 his3 trpl ade8
RAS2val-l9 rasl::PURA3 capsuPC) (9). The cap::HIS3 allele
lacks amino acids 78 to 451 of the coding region of
CAP and, in effect, constitutes the null allele. Strain H1393
(Mata ura3 gcn4::LEU2) is defective at the GCN4 locus
and was the generous gift of A. G. Hinnebusch. Strain JG1
(Mata leu2 ura3 trpl ade8 can] RAS2Val-19 cap: :HIS3::
ADHI-cap 4) was constructed as described below and
expresses the carboxy-terminal 236 amino acids of CAP.
Plasmids. Plasmids used in this study included these
vectors: YEp13M4, a YEp-based plasmid bearing the LEU2
selectable marker, which is identical to the vector YEpM4
described previously (20); pAD4A&, a YEp-based plasmid
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bearing the LEU2 selectable marker and the yeast ADH1
promoter (1); pUV2, a YEp-based plasmid, similar to
YEp13M4, bearing the URA3 selectable marker; and pHV1,
a YEp-based plasmid bearing the HIS3 selectable marker.
For CAP expression studies, the following plasmids were
used: pADH-CAP, which has the coding region of CAP
cloned into the SmaI site of pAD4A and whose expression is
under the control of the ADHI promoter (9); pUADH-CAP,
a plasmid that has the SphI fragment of pADH-CAP cloned
into the SphI site of pUV2 and also allows for expression of
CAP under control of the ADH1 promoter; and pADH-
CAPAl through -16, which are plasmids that have various
deletion mutants of CAP cloned into the SalI and Sacl sites
of pAD4A (see below). For CAP deletion mutant construc-
tion, plasmid pUCAP, which has the Sail-Sacl fragment of
CAP cloned into the Sail and Sacl restriction endonuclease
sites of pUC118, was used. Plasmids used for disrupting the
chromosomal CAP locus, pHSPN5 and pHADA4, are de-
scribed below.
For assaying the yeast general control nondepressing
(GCN) pathway, we used the following plasmids: p238, a
URA3 centromere plasmid that constitutively expresses
GCN4 (19); and p180, a URA3 centromere plasmid which
bears a gene fusion between the upstream regulatory se-
quence of GCN4 and the lacZ gene of E. coli (11). Both
plasmids were a gift of A. G. Hinnebusch. Other fusion
plasmids used in these experiments included pAB177 and
pAB93, which are URA3 centromere plasmids bearing gene
fusions between the upstream regulatory regions of HIS4
and HIS3, respectively, and the lacZ gene. These plasmids
were the gift of K. Arndt.
Phenotypic assays. To assay the ability to grow on YPD,
transformed yeast strains grown on SC-leu were replica
plated onto YPD plates, incubated at 30°C, and examined 48
h later. To assay for temperature sensitivity, transformed
yeast strains grown on SC-leu were replica plated onto
prewarmed SC-leu plates, incubated at 37°C, and examined
72 h later. To assay for heat shock sensitivity (25), trans-
formed yeast strains were grown on SC-leu for 48 h prior to
heat shock. Cells were replica plated onto preheated SC-leu
plates, which were then further incubated at 55°C for various
time intervals (5 to 20 min). After heat shock, plates were
allowed to cool and were incubated at 30°C for 72 h. To
assay for nitrogen starvation sensitivity, transformed yeast
strains were patched onto SC-leu plates, allowed to grow for
2 days, and then replica plated onto YNB plates containing
2% glucose. The YNB plates were then incubated for 9 days
at 30°C. After this time, replicas were made onto SC-leu
plates and then incubated for another 72 h at 30°C to monitor
viability (30).
To assay for amino acid toxicity, yeast strains were
seeded at a density of 2 x 105 cells per ml into SC containing
various amino acids. Cultures were allowed to grow for 48 to
72 h at 25°C, after which aliquots were removed to determine
cell density. Cell density was determined by direct counting
using a hemacytometer or by the measurement of optical
density at 595 nm (OD595). A blank value for the medium was
subtracted from the optical density reading obtained from
each sample.
To assay for defects in the GCN pathway, we first tested
for the toxicity of 3-aminotriazole (3AT; 3-amino-1,2,4-
triazole; Sigma). Transformed yeast strains carrying a HIS3
selectable marker were grown as patches on synthetic selec-
tive medium prior to replica plating onto SC-his plates
containing 10 mM 3AT and 5 mM leucine. The presence of
an inducible HIS3 allele is required by yeast cells to over-
come the toxicity of 3AT (reviewed by Hinnebusch [12]).
Excess leucine is added to enhance the toxicity in gcn4
mutant cells. After replica plating, the plates were allowed to
grow for 48 h at 30°C and were then examined. To assess the
integrity of the GCN pathway, we tested plasmids bearing
gene fusions between the upstream regulatory sequences of
GCN4, HIS4, or HIS3 and a reporter gene, lacZ (see above).
In wild-type yeast cells induced with 3AT, these gene
fusions express P-galactosidase, whose activity can be as-
sayed by using a chromogenic substrate, X-Gal (5-bromo-4-
chloro-3-indolyl-,-D-galactoside; Boehringer Mannheim).
Induction of ,B-galactosidase activity from the GCN4-lacZ
fusion occurs when the GCN pathway upstream of GCN4 is
functional. Induction of P-galactosidase activity from the
HIS4-lacZ and HIS3-lacZ fusions occurs when the GCN
pathway is functional with respect to the HIS4 and HIS3
loci. Yeast strains transformed with plasmids carrying gene
fusions were grown on selective medium prior to replica
plating onto SC-his plates containing 40 ,ug of X-Gal per ml
with or without added 3AT (10 mM). Yeast strains were also
replica plated onto YPD plates as a control for the growth of
cap strains. Yeast patches which turned blue as a function of
P-galactosidase activity were scored as positive in their
response to challenge with 3AT. For enzymatic assays,
liquid cultures of the above-mentioned strains were grown in
SC-his,ura. During logarithmic phase growth, 3AT was
added to a final concentration of 10 mM, and culture samples
were removed at 0, 4, and 8 h after addition. Cells were
collected for assay by centrifugation, washed, and resus-
pended in 0.01 volume of ice-cold extraction buffer contain-
ing 0.1 M Tris-HCl (pH 8.0), 20% (vol/vol) glycerol, 1 mM
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 ,ug of
aprotinin per ml, 10 ,ug of leupeptin per ml, and 10 ,ug of
soybean trypsin inhibitor per ml. Cell lysates were prepared
according to Rose et al. (23). P-Galactosidase assays were
performed as described by Miller (18). ,-Galactosidase
activity measured in the various lysates was normalized for
protein concentration. During culture, cell growth was mon-
itored by optical density. After addition of 3AT, CAP strains
continued to grow, while cap mutant strains showed reduced
growth. No cell lysis was observed after the addition of 3AT.
DNA manipulations. DNA restriction endonucleases, Taq
polymerase, and T4 DNA ligase were used as recommended
by the suppliers (New England BioLabs, Inc.; United States
Biochemical Corp.; Cetus Corp.). Molecular cloning tech-
niques were performed as described by Maniatis et al. (17).
The polymerase chain reaction (PCR) (24) was carried out as
follows: DNA amplification was done in a reaction mixture
containing 50 mM KCl, 10 mM Tris-HCl (pH 8.4), 3 mM
MgCl2, 0.01% (wt/vol) gelatin, 1 U of Taq polymerase, 100
pmol of oligonucleotide primers, and 10 ng of Scal-linearized
pUCAP (see below) in a final volume of 50 [lI. The condi-
tions used for PCR were 30 cycles of denaturation (95°C, 1.5
min), annealing (50°C, 3 min), and extension (72°C, 5 min).
The PCR products were cleaved with the appropriate restric-
tion enzymes, size fractionated by using gel electrophoresis,
electroeluted, and subcloned into pAD4A (see below).
Construction of deletion mutants of CAP. We created three
types of CAP deletions: internal deletion mutants, 5' trun-
cation mutants, and 3' truncation mutants. Mutant CAP
genes are designated Ax-y, where the nucleic acid sequence
between x and y, inclusive, is removed. Numbering of the
nucleic acid sequence of CAP is as appears in Field et al. (9).
For all deletion mutants, we first subcloned CAP into
pUC118 to create plasmid pUCAP (see above).
For internal deletions within the gene, we used existing
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restriction endonuclease sites. pUCAP was cleaved with the
appropriate restriction endonucleases; the ends were reli-
gated and transformed into the bacterial strain HB101. The
resulting plasmids were analyzed by restriction endonucle-
ase cleavage to verify their structures. For deletion mutant
AS05-1498 (A6), restriction enzymes Eco47III and SnaBI
were used. For deletion mutant A505-1105 (A7), restriction
enzymes Eco47III and StuI were used. For deletion mutant
A1105-1498 (A8), restriction enzymes StuI and SnaBI were
used. For deletion mutant A1067-1413 (A14), restriction
enzyme StyI was used. All of these deletion mutants except
A14 maintained the reading frame of the gene. The A14
mutation resulted in a frameshift at bp 1067 and the creation
of a termination codon 15 bases downstream. In effect,
therefore, A14 is a 3' truncation mutant. These mutant genes
were digested with restriction endonucleases SalI and Sacl
prior to subcloning in pAD4A& (see below for additional
details).
Truncations at either the 5' or 3' end ofCAP were made by
using PCR. PCR amplification of mutant CAP genes used
oligonucleotide primers complementary to the coding region
of CAP and to the region flanking the polycloning site in
pUCAP. For 5' deletions, a forward oligonucleotide primer
complementary to the 5' coding region of CAP and a reverse
oligonucleotide primer complementary to the 3' vector se-
quence were used. For 3' deletions, a forward oligonucleo-
tide primer complementary to the 5' vector sequence and a
reverse oligonucleotide primer complementary to the 3'
coding region of CAP were used. Oligonucleotide primers
complementary to the coding region of CAP contained
mismatches in order to create the proper initiation or termi-
nation codons, as well as restriction endonuclease sites, in
the resulting CAP PCR product. A Sall site is found 5' to
CAP, and a Sacl site is present 3' to CAP in the polycloning
site of pUCAP. Forward oligonucleotide primers comple-
mentary to the coding region of CAP contain a Sall restric-
tion endonuclease site. Reverse oligonucleotide primers
complementary to the coding region of CAP contain a SacI
restriction endonuclease site. Therefore, all PCR products
contain a 5' SalI site and a 3' SacI site. The oligonucleotide
primers used for creating the various 5' and 3' deletions in
CAP are listed below:
To express the various deletion mutants of CAP, we
subcloned the mutant genes into the unique SalI and SacI
restriction endonuclease sites in the high-copy-number yeast
expression vector pAD4A (1). This vector carries the S.
cerevisiae LEU2 auxotrophic marker and a polycloning site
downstream of the S. cerevisiae ADHI promoter. After
subcloning, the correct structures of the resulting plasmids
were determined by restriction endonuclease cleavage.
Chromosomal integration of a mutant allele of CAP. To
explore more fully the effect of expressing the C-terminal
domain of CAP in yeast cells, we created a strain that stably
expresses a mutant cap A4 gene from the CAP locus. The
integration plasmid pHADA&4 was created by subcloning an
EcoRV-SnaBI fragment of pADH-CAPA4, which contains
the ADHI promoter and the cap A4 mutant gene, into the
SnaBI site of CAP in the pHSPN5 CAP disruption plasmid
(9). Plasmid pHSPN5 contains the CAP gene disrupted
between NsiI and HpaI sites with the HIS3 gene and was
used to create strains SKN34 and SKN37 as previously
described (9). This new plasmid, pHADA4, was digested
with EcoRI, and the resulting fragments were used to
transform yeast strain TK161-R2V. When yeast cells pos-
sessing the RAS2VaIl9 allele are transformed with this plas-
mid, they become resistant to prolonged heat shock and
nitrogen starvation. One transformant strain was designated
JG1. The disruption of CAP in this strain was confirmed by
Southern blot analysis, and expression of the capA4 gene
product was verified by Western immunoblot analysis. We
call this allele cap::HIS3::ADHI-capA4.
Western analysis of mutant CAP proteins. The expression
of mutant CAP proteins was analyzed by Western blotting.
Briefly, 100 to 150 ml of log-phase cultures (OD595 = 0.5) of
cap SKN37 cells, transformed with various deletion mutants
of CAP, were harvested by centrifugation. Cell pellets were
washed twice in 10 mM Tris-HCl-l mM EDTA (pH 7.0) and
frozen at -70°C for later use. Thawed cell pellets (150 ,ul)
were resuspended in 350 ,il of ice-cold extraction buffer
containing 1% Nonidet P-40, 0.5% deoxycholate, 0.1% so-
dium dodecyl sulfate, 150 mM NaCl, 50 mM Tris-HCl (pH
8.0), leupeptin (10 jig/ml), soybean trypsin inhibitor (10
pug/ml), aprotinin (10 jig/ml), and 100 ,uM phenylmethylsul-
fonyl fluoride. Washed glass beads (300 ,u) were then added,
A4-93 (Al)
A4-300 (A2)
A4-561 (A3)
A4-870 (A4)
A4-1068 (A5)
A1495-1581 (All)
A1369-1581 (A12)
A853-1581 (A15)
A577-1581 (A16)
forward: 5'-GAT
reverse: 5'-CAC
forward: 5'-TAT
reverse: 5'-CAC
forward: 5'-CCT
reverse: 5'-CAC
forward: 5'-CAG
reverse: 5'-CAC
forward: 5'-AAT
reverse: 5'-CAC
reverse: 5'-CAG
forward: 5'-ACG
reverse: 5'-TAT
forward: 5'-ACG
reverse: 5'-TTT
forward: 5'-ACG
reverse: 5'-TCC
forward: 5'-ACG
TAG
ACA
CAG
ACA
GGG
ACA
CTT
ACA
CCG
ACA
GGA
ACG
CAA
ACG
CAA
ACG
AAA
ACG
AGG
GGA
GAA
GGA
TTG
GGA
CCG
GGA
GTC
GGA
TTG
TTG
TGG
TTG
AGA
TTG
ACT
TTG
ATG
AAC
AGG
AAC
CAG
AAC
TCG
AAC
GAC
AAC
GGA
TAA
AGC
TAA
CGG
TAA
GAG
TAA
TCG
AGC
TCG
AGC
TCG
AGC
ACG
AGC
CCA
AGC
GCT
ACC
TCT
AAC
GAG
AAC
CTC
AAC
ACA
TAT
ACA
TAT
ACA
TAT
AAA
TAT
CAA
TAT
CTA
GAC
AAG
GAC
CTC
GAC
CGT
GAC
TGT
GAC
TGG
GAC
CTC
GAC
TCT
GAC
TGC
GAC
CTT
GGC
GTA
GGC
ATG
GGC
CCT
GGC
ATC AAG AAG GT
CAT-3'
TGG TCT TAG AT
CAT-3'
CCG TGT-3'
CAT-3'
CTA ATG ATA CA
CAT-3'
CAA AAA AGC-3'
CAT-3'
AAT CAT CGT-3'
CAG T-3'
GGG AAT-3'
CAG T-3'
GGG CTG GTG-3'
CAG T-3'
AGA AAT CTG TG
CAG T-3'
rG-3'
WC-31
MOL. CELL. BIOL.
rT-31
-NA-31
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FIG. 1. Effects of increasing concentrations of valine on the growth of cap cells. Synthetic medium lacking valine was inoculated with
SKN37 cells transformed with plasmids expressing either full-length CAP (CAP) or deletion mutants of CAP (A4, A6, A7, and All) or with
a yeast expression vector alone (YEpl3M4). Valine was added in increasing concentrations (0 to 5 mM). Cultures were allowed to grow for
48 h at 25°C before measurements of optical density were taken. One optical density unit corresponds to approximately 6.0 x 106 cells per
ml. The deletion mutant of CAPA4 expresses the C-terminal domain of CAP. Deletion mutants CAPA6 and -All express the N-terminal
domain, while A7 contains both domains (see Fig. 4).
and the cells were disrupted by prolonged vortexing at 4°C
(1-min intervals followed by chilling) using a Bead Beater
(Biospec Products). The resulting extracts were clarified by
centrifugation for 1 min at 12,000 x g, and the protein
concentration of each sample was determined by using the
BCA protein assay method (Pierce). Samples (50 to 125 ,ug
per lane) were loaded on to 10% polyacrylamide gels pre-
pared according to Laemmli (15). Samples were gel electro-
phoresed and blotted onto GeneScreen Plus membranes
(New England Nuclear) as described by Peluso and Rosen-
burg (21). Membranes were blocked in 5% nonfat dry milk in
phosphate-buffered saline (PBS). After repeated washing of
membranes in PBS containing 1.5% bovine serum albumin
and 0.5% gelatin (PBG), they were incubated with polyclonal
antisera (1:200 dilution) raised against full-length CAP ex-
pressed in E. coli (9). After the membranes were washed in
PBG, they were probed with 5 ,uCi of 1251-protein A (ICN
Biomedicals), washed, dried, and autoradiographed on
Kodak XAR-5 film.
RESULTS
Nutrient responses of cap cells. We have previously shown
that disruption of the CAP allele, by deletion of the coding
region and insertion of a selective marker gene, results in
haploid yeast strains that grow in synthetic minimal medium
but fail to grow in rich medium (YPD) (9). To examine this
phenotype further, we separately tested yeast extract and
Bacto-Peptone, two components of rich medium. For these
experiments, we used the cap mutant strain SKN37 (see
Materials and Methods for strain descriptions). When added
to synthetic minimal medium at standard concentrations,
both yeast extract (10 mg/ml) and Bacto-Peptone (20 mg/ml)
were toxic to this strain (data not shown). This toxicity was
found to be dose dependent. Both Bacto-Peptone and yeast
extract are rich in amino acids. We therefore next tested the
effect of Casamino Acids, an acid hydrolysate of casein, on
the growth of SKN37 cells. This supplement was also toxic
at concentrations that highly stimulate the growth of wild-
type yeast cells. We then tested individual amino acids for
toxicity by adding them to synthetic medium. Two aliphatic
amino acids, valine and alanine, were found to be toxic to
SKN37 cells, at concentrations which were not toxic to
wild-type cells. To confirm that this phenotype resulted from
the cap genotype, we transformed SKN37 cells with plas-
mids expressing either full-length or truncated CAP, or with
vector alone, and seeded transformants in synthetic liquid
medium containing increasing concentrations of valine.
Growth was monitored by measuring optical density. Cells
expressing full-length CAP grew as expected, while cells
lacking CAP showed a concentration-dependent growth in-
hibition (Fig. 1). Half-maximal inhibition of the growth of
cap cells was observed at 0.6 mM valine. The concentration
of valine in YPD is approximately 10-fold higher than this
(Difco amino acid analysis, unpublished). The response of
cells expressing truncated CAP will be discussed later.
Toxicity of excess amino acids has been seen in yeast cells
defective in the GCN pathway and can be attributed to
indirect starvation, due to deficiencies in the synthesis of
other amino acids (12). GCN4, a transcriptional regulator of
various amino acid biosynthetic enzymes, is directly in-
volved in the response to amino acid starvation in yeast cells
(12). 3AT, which produces a metabolic block for the synthe-
sis of histidine, is known to arrest the growth of gcn4 cells,
because such cells are unable to derepress transcription of
the histidine biosynthetic enzymes (13). Similarly, we found
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Strain
cap
+ CAP
+GCN4
MOL. CELL. BIOL.
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+ GCN4-LacZ
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SC + X-Gal SC+ X-Goi
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CAP_
__-(-
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FIG. 2. Effects of CAP and GCN4 on the growth of cap and gcn4
yeast strains on media containing 3AT. Strains SKN37 (cap) and
H1393 (gcn4) were transformed with either a high-copy-number
plasmid expressing full-length CAP (pUADH-CAP) or a centromere
plasmid constitutively expressing GCN4 or with yeast expression
vector pUV2 (blank). All plasmids contained the URA3 selectable
marker (see Materials and Methods). Transformants were grown
and plated as described in Materials and Methods. The column
labeled Control represents plates containing synthetic medium lack-
ing 3AT; the column labeled +3AT represents plates containing
synthetic medium plus 10 mM 3AT.
that cap cells also failed to grow on synthetic medium
containing 10 mM 3AT, while wild-type cells were unaf-
fected (not shown). To determine whether the GCN pathway
was defective in cap mutant cells and thus unable to correct
for a possible amino acid imbalance in cap mutant cells, we
transformed cap mutant strain SKN37 and gcn4 strain
H1393 with plasmids expressing either CAP or GCN4. We
then tested the ability of transformants to grow on synthetic
medium containing 3AT (Fig. 2). A control plasmid, pUV2,
was also used in these experiments (see Materials and
Methods for plasmid descriptions). The toxicity of 3AT to
cap mutant cells was corrected by the expression of CAP but
not by the constitutive expression of GCN4. Correspond-
ingly, the defect in gcn4 cells could be corrected by the
expression ofGCN4 but not by the expression of CAP. Since
GCN4 is a transactivator of the histidine biosynthetic en-
zymes, this result makes it highly unlikely that cap mutant
cells are defective in growth in the presence of 3AT because
of defects in the GCN pathway. This conclusion is further
strengthened by additional experiments using lacZ fusion
genes as reporters for induction of the GCN response (11,
12, 16). We determined that the GCN pathway was function-
ing properly in cap mutant cells. Reporters for HIS4, HIS3,
and GCN4 are induced with 3AT, as can be seen in plate
assays (Fig. 3) and enzymatic assays (data not shown).
For plate assays (see Materials and Methods for descrip-
tion), we used the wild-type CAP (CAPWt) strain SP1 and cap
mutant strain SKN37 transformed with reporters for both
GCN4 and HIS4 as well as control plasmids pUV2 and
pHV1. Both strains carried the URA3 and HIS3 selectable
markers. Wild-type yeast cells were induced for both re-
porter genes by growth on synthetic medium containing
3AT, as judged by the accumulation of blue color. Similarly,
the reporter genes in cap mutant cells were strongly induced
in the presence of 3AT and accumulated even more color
than did wild-type strains. In addition, cap mutant strains
showed some accumulation of color even in the absence of
3AT. These results suggest that the GCN pathway is intact
+
-GCN4-LaCZ
+ HIS4-LocZ
FIG. 3. Effects of 3AT on GCN4-lacZ and HIS4-lacZ expression
in CAP' and cap strains. Strains SP1 (CAPW) and SKN37 (cap)
were transformed with centromere plasmids bearing fusions be-
tween lacZ and the upstream regulatory sequences of GCN4
(GCN4-1acZ) or HIS4 (HIS4-lacZ) or with yeast expression vector
pUV2 (blank). All plasmids carried the URA3 selectable marker.
3-Galactosidase activity was visualized on synthetic selective me-
dium containing either X-Gal (40 ,|g/ml) alone (SC+X-Gal) or X-Gal
and 10 mM 3AT (SC+X-Gal+3AT) to induce the GCN pathway.
The dark patches in this black-and-white photograph reflect the
induction of the blue pigment resulting from the production of
P-galactosidase. See Materials and Methods for further description.
and functional in cap mutant cells. To verify the results of
the plate assays and to rule out the possibility that the strong
color accumulation in cap mutant cells results from cell lysis
and the leakage of P-galactosidase into the medium, we
performed P-galactosidase enzymatic assays on cells cul-
tured in liquid medium. For this experiment (see Materials
and Methods for description), we also tested a HIS3-lacZ
reporter. ,-Galactosidase enzymatic assays performed on
wild-type and cap mutant yeast cells demonstrated, in both
cases, a strong stimulation of ,-galactosidase activity within
4 to 8 h after the addition of 3AT to the culture medium (not
shown). The levels of reporter gene activity in cap mutant
strains were also higher than that of the wild-type SP1 strain
both before (zero time) and after the addition of 3AT (data
not shown).
Deletion analysis of CAP. The sequence of CAP is note-
worthy: this 526-amino-acid protein contains a sequence of
six consecutive prolines, and amino acid positions 273
through 286 consist solely of proline or alanine residues (9).
This proline-rich stretch divides CAP into two domains. To
test the function of these domains, various deletion mutants
in the CAP gene were made (Fig. 4). Deletion mutants of
CAP were tested for biological activity following trans-
formation into various yeast strains. Three strains were
used: SKN34 (cap mutant RAS2W'), SKN37 (cap mutant
RAS2val-19), and TKR1-2LS (capsuPc RAS2val-l9). We mon-
itored these phenotypes: temperature sensitivity; ability to
grow on rich medium (YPD); ability to withstand deprivation
of a nitrogen source; and heat shock sensitivity. Western
blots confirmed that our stains expressed mutant CAP pro-
teins of the correct size (Fig. 5). Such analysis also demon-
strated that the amount of CAP in transformed strains was
similar to the amount of CAP expressed by wild-type cells
(data not shown).
cap mutant SKN34 cells show temperature-sensitive
growth on synthetic medium, are unable to grow on rich
medium, and are acutely sensitive to nitrogen starvation.
SKN34 cells transformed with the full-length CAP gene
regain the wild-type phenotypes (Fig. 4). Expression of a
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FIG. 5. Western analysis of mutant CAP proteins. The expres-
sion of mutant CAP proteins was demonstrated by Western analy-
sis. Whole-cell extracts (125 p.g of protein per lane) from SKN37
cells transformed with full-length CAP (pADH-CAP), with deletion
mutants of CAP (pADH-CAPA1, -A4, -A6, -A7, -A12, and -A15; see
Fig. 4), or with a yeast expression vector (YEp13M4) as a control
were electrophoresed on a 10% polyacrylamide gel and blotted as
described in Materials and Methods. Blots were subsequently
incubated with polyclonal antisera (1:200) raised against E. coli-
expressed full-length CAP and were probed with 1251I-protein A. The
migration of prestained molecular weight markers is shown on the
left.
C-terminal region of CAP as small as 237 amino acids
appears to be sufficient for restoring the wild-type pheno-
types (Fig. 4). In contrast, expression of the N-terminal
region of CAP, even when including the middle proline-rich
region, had no effect on the cap mutant phenotypes of this
strain. Thus, the C-terminal domain is required for suppres-
sion of these cap mutant phenotypes and appears sufficient
by itself. In addition, cells expressing the C-terminal domain
of CAP were also resistant to valine and 3AT toxicity, while
cells expressing the N-terminal domain alone remained
sensitive (Fig. 1 and data not shown). Thus, the toxicity of
valine and 3AT, temperature sensitivity, sensitivity to star-
vation, and sensitivity to rich media are all associated with
the function of the carboxy-terminal region of CAP.
To explore the effects of deletions in CAP on the response
of cells to activated RAS, we introduced the CAP mutants
into strain SKN37, which expresses the activated RAS2Val-l9
gene. CAPWt strains are sensitive to both heat shock and
nitrogen starvation when they express the RAS2Val-19 gene
(25, 30). SKN37, however, is not heat shock sensitive yet
remains sensitive to nitrogen deprivation and displays the
other defects typically seen in cap mutant strains. The
sensitivity to nitrogen deprivation seen in cap mutant
RAS2val`l9 cells probably results from the disruption of CAP
and not from penetrance of the activated RAS2 allele.
Consistent with this idea and with the results described
above, the introduction into SKN37 of mutants expressing
only the C-terminal domain of CAP restored the ability to
grow in rich medium, survive nitrogen deprivation, and grow
at 37°C. However, these mutant CAP genes did not restore
heat shock sensitivity to SKN37 and thus do not confer
penetrance of the activated RAS2Val-l9 allele. In contrast,
expression of as little as the first 192 amino acids of CAP was
sufficient to render SKN37 cells sensitive to heat shock.
Even small deletions of the N-terminal portion of CAP
destroy its ability to render SKN37 cells sensitive to acti-
vated RAS (Fig. 4). Suppression of glycogen accumulation,
another phenotype of activated RAS (14, 28), also requires
expression of the CAP N-terminal domain (data not shown).
Therefore, the N-terminal domain, comprising amino acids 1
through 192, appears both necessary and sufficient for the
expression of the phenotypes associated with activated
RAS.
Similar conclusions about the N-terminal domain of CAP
can also be inferred from our experiments with the caps"Pc
RAS2Val-l9 strain TKR1-2LS. Experiments with this strain
(Fig. 4) further demonstrate that the N-terminal domain of
CAP, when expressed separately, has a dominant effect over
the mutant allele.
Cells expressing mutant CAP proteins containing com-
plete N-terminal and C-terminal domains, but entirely lack-
ing the middle portion of the gene, behave like CAPWt cells
in our assays. Hence the proline-rich region does not appear
to be essential for the functions that we have assayed.
We further note that expression of the C-terminal domain
of CAP in CAPWt RAS2Val-19 cells was unable to reverse
either the heat shock or nitrogen starvation phenotype (data
not shown). In addition, the N-terminal domain of CAP did
not render a CAPWt RASWt strain heat shock sensitive (data
not shown). Thus, the truncated CAP proteins do not appear
to have dominant interfering effects in CAPWt cells.
Morphological abnormalities in cells expressing only the
C-terminal domain of CAP. We next examined the effects of
expressing the domains of CAP on the morphology of yeast
cells. We observe a wide range of cell sizes in growing
cultures of cap mutant cells (9). Many cap mutant cells are
extremely rounded and large. cap mutant strain SKN37 was
transformed with high-copy-number plasmids expressing
various domains of CAP. N-terminal portions of CAP that
were capable of restoring the sensitivity to cells to activated
RAS were not capable of restoring normal cell morphology
(data not shown). On the other hand, cultures of cells
expressing the C-terminal portion of CAP contained greater
numbers of morphologically normal cells. Even in such
cultures, however, morphologically abnormal cells are seen.
From these observations, we conclude that the morphologic
abnormality of cap mutant cells results from loss of the
C-terminal portion of CAP and can be at least partially
restored by expressing that region.
The incomplete suppression of morphologic abnormalities
seen in cap mutant cells expressing C-terminal portions of
CAP from high-copy-number plasmids may have been due to
plasmid instability. To circumvent the problems associated
with the instability of high-copy-number plasmids, we cre-
ated strain JG1. This strain expresses the C-terminal 237
amino acids of CAP (cap"*4) from an ADHI promoter inte-
grated at the CAP locus. Expression of the wild-type CAP
gene is completely ablated (see Materials and Methods). JG1
grows well in rich medium, but it is not heat shock sensitive
or sensitive to starvation even though it contains the
RAS2VaI-l9 allele. We have determined by Western blot
analysis that the level of expression of truncated CAP
protein in JG1 is comparable to the level of expression of
full-length CAP protein seen in wild-type cells (data not
shown). Expression of full-length CAP in JG1 restored the
phenotypes associated with activated RAS (data not shown).
When JG1 cells are in log phase in synthetic medium they are
similar in size to CAPWt RAS2val-19 cells, although they are
more round in shape. In contrast, cultures grown in rich
medium or in synthetic medium containing elevated concen-
trations of valine display the distinctly enlarged cells seen in
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FIG. 6. Effect of valine on the morphology of CAP"' and cap"4 strains. Strains TK161-R2V (RAS2val-19 CAP-) and JG1 (RAS2va-l9
ADHJ-cap"4) were seeded and grown in liquid culture with either synthetic medium lacking valine (SC) or synthetic medium containing 5 mM
valine (SC + Valine). Cultures in log-phase growth were harvested by centrifugation (5 min at 1,500 x g) and examined microscopically. See
text for details.
cultures of cap mutant strains (Fig. 6). Many of these cells
also appear to have enlarged vacuoles, a feature typical of
cap mutant cells. Thus, the constitutive expression of the
C-terminal domain of CAP does not fully compensate for the
morphological effects caused by disruption of the wild-type
allele.
DISCUSSION
RAS proteins are ubiquitous in evolution. Their function is
unknown except in S. cerevisiae. In that yeast, RAS regu-
lates adenylyl cyclase but probably has other functions as
well (31). While investigating the mechanism by which RAS
proteins stimulate adenylyl cyclase in S. cerevisiae, we
found a protein, which we have called CAP, that copurifies
with RAS-responsive adenylyl cyclase.
CAP appears to be a truly bifunctional protein, and each
function is associated with a separate protein domain. cap
mutant cells display two sets of seemingly unrelated pheno-
types. The first includes morphologic abnormality, temper-
ature sensitivity, sensitivity to nitrogen starvation (9), inabil-
ity to grow in rich medium, amino acid toxicity, and
sensitivity to metabolic block by 3AT (this report); the
second is a loss of cellular responsiveness to activated RAS
(9). The first set of phenotypes appears to correlate with loss
of expression of the C-terminal domain of CAP and is
restored to cap mutant cells by expression of that domain.
As we have demonstrated previously, the phenotypes of
temperature sensitivity, morphologic abnormality, and fail-
ure to grow in rich medium associated with loss of CAP
function are not reversed by overexpression of the yeast A
kinase or cyclic AMP phosphodiesterase gene (9). Thus, the
functions of the C-terminal domain of CAP do not appear to
be related to the one known target for RAS action, namely,
adenylyl cyclase. In contrast, loss of responsiveness to
activated RAS correlates with a loss of expression of the
N-terminal domain of CAP and can be restored to cap
mutant cells by expression of that domain. The phenotypes
associated with activated RAS are undoubtedly due, at least
in part, to its effects on adenylyl cyclase (25, 30). Cells that
contain the supC or srv2 allele of CAP are resistant to the
effects of RAS2Val-19 but show none of the other phenotypes
of cap cells (7, 9). We speculate that these alleles contain
mutations that alter the N-terminal domain of CAP but do
not alter the function of the C-terminal domain of CAP.
The two domains of CAP can function independently.
Nevertheless, the C-terminal domain does not appear to
function completely correctly in the absence of the N-termi-
nal domain. Indeed, strain JG1, which expresses only the
C-terminal domain of CAP, has a normal growth response to
nutrient extremes, but cultures of JG1 accumulate morpho-
logically abnormal cells upon prolonged growth in rich
medium. Our assays for CAP function may not be suffi-
ciently sensitive to detect important interactions between
the N-terminal and C-terminal domains. A low level of
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function of the C-terminal domain may be sufficient to allow
the cell to respond to nutrient stress through other regulatory
mechanisms. We have previously encountered redundant
regulatory controls in yeast cells. For example, cells without
regulatory control of their A kinase pathway lack the ability
to respond to some nutrient extremes, yet if the unregulated
A kinase activity is sufficiently attenuated by mutation, cells
regain this ability (5).
cap mutant cells are intolerant of either nitrogen depriva-
tion or an excess of amino acids. Cells deficient in the GCN
pathway are also sensitive to extremes in the availability of
amino acids (12). The growth of gcn4 strains may be inhib-
ited by the excess of some amino acids because feedback
inhibition decreases the synthesis of other amino acids. A
similar mechanism may be operant in cap mutant cells,
which are growth inhibited by the excess of amino acids such
as valine. However, despite the similarity in nutrient re-
sponses of gcn mutant and cap mutant strains, we can
observe no functional relationship between these pathways.
The GCN response in cap mutant cells appears to function
properly, and hence we must look elsewhere for an expla-
nation of its responses to amino acid imbalances. We do not
know, in fact, whether cap mutant cells even have a defect
in protein biosynthesis. It is possible, for example, that the
primary defect in cap mutant cells results in an inefficient
assembly of newly synthesized protein into new cellular
components.
CAP appears to fulfill two regulatory roles in nutrient
sensing in S. cerevisiae. Its N-terminal domain is required
for cellular responsiveness to activated RAS. RAS modu-
lates cellular responses to nutrient stress (14, 29). Cells with
constitutively activated RAS are unresponsive to nutrient
deprivation. They remain heat shock sensitive even when
growth is arrested and lose viability when starved. These
responses are probably mediated by the effects of RAS on
adenylyl cyclase (25, 30). We do not understand why the
presence of the N-terminal of CAP is needed for the normal
cellular responses to activated RAS, but we presume that
this CAP domain is required for the proper regulation of
adenylyl cyclase (9). Our present work demonstrates that the
C-terminal domain of CAP is required for another pathway
regulating responses to nutrient stresses. We presume that
the two regulatory pathways, which are both embedded in
the CAP protein, are in some way functionally linked. Many
possible models can be envisioned which incorporate RAS,
adenylyl cyclase, CAP, and possibly cytoskeletal compo-
nents into the growth-regulatory circuitry of the cell. Addi-
tional biochemical and genetic experiments are required to
develop a model.
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